Sep 30, 2026
A diagnosis of localized prostate cancer places a patient at a critical crossroads. When biopsy results reveal low-risk or favorable intermediate-risk disease—specifically…
Read More →
Sep 29, 2026
Preserving and restoring erectile function following radical prostatectomy remains one of the most critical aspects of post-surgical survivorship. While modern nerve-sparing techniques…
Read More →
Sep 28, 2026
Urinary continence is one of the most critical determinants of quality of life following radical prostatectomy. While oncologic cure remains the primary…
Read More →
Sep 25, 2026
The widespread use of multiphasic contrast-enhanced CT scans and abdominal MRIs has led to the routine detection of incidental small renal masses.…
Read More →
Sep 24, 2026
Primary radiation therapy—including external beam radiation therapy (EBRT), stereotactic body radiation therapy (SBRT), proton beam therapy, and brachytherapy (radioactive seed implants)—along with…
Read More →
Sep 22, 2026
Radical prostatectomy has long been recognized as a benchmark curative therapy for localized prostate cancer. However, the procedure historically confronted surgeons with…
Read More →
Sep 04, 2026
Receiving a prostate cancer diagnosis triggers an immediate reaction to seek prompt removal of the tumor. However, for a select group of…
Read More →
Sep 03, 2026
For decades, genetic screening for BRCA1 and BRCA2 gene mutations was viewed almost exclusively through the lens of women’s health. However, modern…
Read More →
Sep 02, 2026
In recent years, “focal therapy”—which includes High-Intensity Focused Ultrasound (HIFU), cryotherapy, photodynamic therapy, and irreversible electroporation (NanoKnife)—has been widely marketed as a…
Read More →
212-365-5000